Structural determinants for alternative splicing regulation of the MAPT pre-mRNA

RNA Biology

Volumn 12, Issue 3, 2015, Pages 330-342

  Lisowiec, Jolanta ^a   Magner, Dorota ^a   Kierzek, Elzbieta ^a   Lenartowicz, Elzbieta ^a   Kierzek, Ryszard ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

Alternative splicing regulation; Antisense oligonucleotides; Neurodegradation; RNA structure; RNA thermodynamics; Small molecule binding

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; KANAMYCIN; MESSENGER RNA PRECURSOR; MITOXANTRONE; NEOMYCIN; PEPTIDE FRAGMENT; TOBRAMYCIN; ANTIINFECTIVE AGENT; LIGAND; MAPT PROTEIN, HUMAN; RECOMBINANT PROTEIN; RNA PRECURSOR; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; DNA TEMPLATE; EXON; GENE; GENE CONTROL; HUMAN; MAPT GENE; MELTING POINT; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE ANALYSIS; RNA FOLDING; RNA HYBRIDIZATION; RNA STRUCTURE; RNA SYNTHESIS; THERMODYNAMICS; WILD TYPE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CHLOROCEBUS AETHIOPS; CONFORMATION; COS 1 CELL LINE; ENHANCER REGION; GENETICS; INTRON; METABOLISM; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; RNA STABILITY; SILENCER ELEMENT; SYNTHESIS;

ALTERNATIVE SPLICING; ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; ENHANCER ELEMENTS, GENETIC; EXONS; HUMANS; INTRONS; LIGANDS; MICROARRAY ANALYSIS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; RECOMBINANT PROTEINS; RNA PRECURSORS; RNA STABILITY; SILENCER ELEMENTS, TRANSCRIPTIONAL; TAU PROTEINS; THERMODYNAMICS;

EID: 84929324423     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2015.1017214     Document Type: Article

References (64)

1. Lee CJ, Irizarry K. Alternative splicing in the nervous system: an emerging source of diversity and regulation. Biol Psychiatry 2003; 54:771-6; PMID:14550676; http://dx.doi.org/10.1016/S0006-3223(03)00375-5
2. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008; 40:1413-5; PMID:18978789; http://dx.doi.org/10.1038/ng.259
3. Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 1992; 31:10626-33; PMID:1420178; http://dx.doi.org/10.1021/bi00158a027
4. Wolfe MS. The role of tau in neurodegenerative diseases and its potential as a therapeutic target. Scientifica (Cairo) 2012; 2012:796024; PMID:24278740; http://dx.doi.org/10.6064/2012/796024
5. Wszolek ZK, Slowinski J, Golan M, Dickson DW Frontotemporal dementia and parkinsonism linked to chromosome 17. Folia Neuropathol 2005; 43:258-70; PMID:16416390
6. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA Multiple isoforms of human microtubule- associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3:519-26; PMID:2484340; http://dx.doi.org/10.1016/0896-6273(89)90210-9
7. Varani L, Hasegawa M, Spillantini MG, Smith MJ, Murrell JR, Ghetti B, Klug A, Goedert M, Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A 1999; 96:8229-34; PMID:10393977; http://dx.doi.org/10.1073/pnas.96.14.8229
8. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 1998; 95:7737-41; PMID:9636220; http://dx.doi.org/10.1073/pnas.95.13.7737
9. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al. Association of missense and 5'- splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393:702-5; PMID:9641683; http://dx.doi.org/10.1038/31508
10. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43:815-25; PMID:9629852; http://dx.doi.org/10.1002/ana.410430617
11. D'Souza I, Schellenberg GD. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J Biol Chem 2000; 275:17700-9; PMID:10748133; http://dx.doi.org/10.1074/jbc.M909470199
12. D'Souza I, Schellenberg GD. tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sites. J Biol Chem 2002; 277:26587-99; PMID:12000767; http://dx.doi.org/10.1074/jbc.M203794200
13. Kar A, Fushimi K, Zhou X, Ray P, Shi C, Chen X, Liu Z, Chen S, Wu JY. RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site. Mol Cell Biol 2011; 31:1812-21; PMID:21343338; http://dx.doi.org/10.1128/MCB.01149-10
14. Ray P, Kar A, Fushimi K, Havlioglu N, Chen X, Wu JY. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10. J Mol Neurosci 2011; 45:453-66; PMID:21881826; http://dx.doi.org/10.1007/s12031-011-9634-z
15. Donahue CP, Muratore C, Wu JY, Kosik KS, Wolfe MS. Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing. J Biol Chem 2006; 281:23302-6; PMID:16782711; http://dx.doi.org/10.1074/jbc. C600143200
16. Varani L, Spillantini MG, Goedert M, Varani G. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics. Nucleic Acids Res 2000; 28:710-9; PMID:10637322; http://dx.doi.org/10.1093/nar/28.3.710
17. Zheng S, Chen Y, Donahue CP, Wolfe MS, Varani G. Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone). Chem Biol 2009; 16:557-66; PMID:19477420; http://dx.doi.org/10.1016/j. chembiol.2009.03.009
18. Monani UR. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 2005; 48:885-96; PMID:16364894; http://dx.doi.org/10.1016/j.neuron.2005.12.001
19. Mathews DH, Sabina J, Zuker M, Turner DH. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 1999; 288:911-40; PMID:10329189; http://dx.doi.org/10.1006/jmbi.1999.2700
20. Reuter JS, Mathews DH. RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics 2010; 11:129; PMID:20230624; http://dx.doi.org/10.1186/1471-2105-11-129
21. Kierzek E. Binding of short oligonucleotides to RNA: studies of the binding of common RNA structural motifs to isoenergetic microarrays. Biochemistry 2009; 48:11344-56; PMID:19835418; http://dx.doi.org/10.1021/bi901264v
22. Wilkinson KA, Merino EJ, Weeks KM. Selective 2'- hydroxyl acylation analyzed by primer extension (SHAPE): quantitative RNA structure analysis at single nucleotide resolution. Nature Protocols 2006; 1:1610- 1616; PMID:17406453; http://dx.doi.org/10.1038/nprot.2006.249
23. Peattie DA, Gilbert W. Chemical probes for higherorder structure in RNA. Proc Natl Acad Sci U S A 1980; 77:4679-82; PMID:6159633; http://dx.doi.org/10.1073/pnas.77.8.4679
24. Kierzek E, Kierzek R, Turner DH, Catrina IE. Facilitating RNA structure prediction with microarrays. Biochemistry 2006; 45:581-93; PMID:16401087; http://dx.doi.org/10.1021/bi051409+
25. Kierzek E, Kierzek R, Moss WN, Christensen SM, Eickbush TH, Turner DH. Isoenergetic penta- and hexanucleotide microarray probing and chemical mapping provide a secondary structure model for an RNA element orchestrating R2 retrotransposon protein function. Nucleic Acids Res 2008; 36:1770-82; PMID:18252773; http://dx.doi.org/10.1093/nar/gkm1085
26. Kierzek E, Christensen SM, Eickbush TH, Kierzek R, Turner DH, Moss WN. Secondary structures for 5' regions of R2 retrotransposon RNAs reveal a novel conserved pseudoknot and regions that evolve under different constraints. J Mol Biol 2009; 390:428-42; PMID:19397915; http://dx.doi.org/10.1016/j. jmb.2009.04.048
27. Kierzek R, Turner DH, Kierzek E. Microarrays for identifying binding sites and probing structure of RNA. Nucleic Acids Res 2014; 43:1-12.
28. Wilkinson KA, Merino EJ, Weeks KM. RNA SHAPE chemistry reveals nonhierarchical interactions dominate equilibrium structural transitions in tRNA(Asp) transcripts. J Am Chem Soc 2005; 127:4659-67; PMID:15796531; http://dx.doi.org/10.1021/ja0436749
29. Dawson WK, Fujiwara K, Kawai, G. Prediction of RNA pseudoknots using heuristic modeling with mapping and sequential folding. PLoS One 2007; 2:e905; PMID:17878940; http://dx.doi.org/10.1371/journal. pone.0000905
30. Dawson W, Fujiwara K, Kawai G, Futamura Y, Yamamoto K. A method for finding optimal rna secondary structures using a new entropy model (vsfold). Nucleosides Nucleotides Nucleic Acids 2006; 25:171-89; PMID:16541960; http://dx.doi.org/10.1080/15257770500446915
31. Gonzalez RL Jr, Tinoco I Jr. Solution structure and thermodynamics of a divalent metal ion binding site in an RNA pseudoknot. J Mol Biol 1999; 289:1267-82; PMID:10373367; http://dx.doi.org/10.1006/jmbi.1999.2841
32. Nakano S, Miyoshi D, Sugimoto N. Effects of molecular crowding on the structures, interactions, and functions of nucleic acids. Chem Rev 2014; 114:2733-58; PMID:24364729; http://dx.doi.org/10.1021/cr400113m
33. Hajdin CE, Bellaousov S, Huggins W, Leonard CW, Mathews DH, Weeks KM. Accurate SHAPE-directed RNA secondary structure modeling, including pseudoknots. Proc Natl Acad Sci U S A 2013; 110:5498-503; PMID:23503844; http://dx.doi.org/10.1073/pnas.1219988110
34. Popenda M, Szachniuk M, Antczak M, Purzycka KJ, Lukasiak P, Bartol N, Blazewicz J, Adamiak RW. Automated 3D structure composition for large RNAs. Nucleic Acids Res 2012; 40:e112; PMID:22539264; http://dx.doi.org/10.1093/nar/gks339
35. D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM, Bird TD, Schellenberg GD. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A 1999; 96:5598-603; PMID:10318930; http://dx.doi.org/10.1073/pnas.96.10.5598
36. Stanford PM., Shepherd CE, Halliday GM, Brooks WS, Schofield PW, Brodaty H, Martins RN, Kwok JB, Schofield PR. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 2003; 126:814-26; PMID:12615641; http://dx.doi.org/; http://dx.doi.org/10.1093/brain/awg090
37. Turner DH. Conformational Changes. in Nucleic Acids Structures, Properties and Functions, Vol. chapter 8 (eds. Bloomfield VA, Crothers DM, Tinoco I, Jr) 259-334 (University Science Books, Sausalito, California, 2000).
38. Thomas JR, Hergenrother PJ. Targeting RNA with small molecules. Chem Rev 2008; 108:1171-224; PMID:18361529; http://dx.doi.org/10.1021/cr0681546
39. Luo Y, Disney MD. Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA. Chembiochem 2014; 15:2041-4; PMID:25115866; http://dx.doi.org/10.1002/cbic.201402069
40. Hartmuth K, Vornlocher HP, Luhrmann R. Tobramycin affinity tag purification of spliceosomes. Methods Mol Biol 2004; 257:47-64; PMID:14769995
41. Sud R, Geller ET, Schellenberg GD. Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies. Mol Ther Nucleic Acids 2014; 3:e204; PMID:25333676; http://dx.doi.org/10.1038/mtna.2014.30
42. Jiang Z., Tang H, Havlioglu N, Zhang X, Stamm S, Yan R, Wu JY. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J Biol Chem 2003; 278:18997-9007; PMID:12649279; http://dx.doi.org/10.1074/jbc.M301800200
43. Qian W, Liang H, Shi J, Jin N, Grundke-Iqbal I, Iqbal K, Gong CX, Liu F. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Res 2011; 39:6161-71; PMID:21470964; http://dx.doi.org/10.1093/nar/gkr195
44. Wang Y, Wang J, Gao L, Stamm S, Andreadis A. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia. Gene 2011; 485:130-8; PMID:21723381; http://dx.doi.org/10.1016/j.gene.2011.06.020
45. Ding S, Shi J, Qian W, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F. Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A. Neurobiol Aging 2012; 33:1389-99; PMID:21215488; http://dx.doi.org/10.1016/j.neurobiolaging.2010.11.021
46. van Abel D, Hölzel DR, Jain S, Lun FM, Zheng YW, Chen EZ, Sun H, Chiu RW, Lo YM, van Dijk M, Oudejans CB. SFRS7-mediated splicing of tau exon 10 is directly regulated by STOX1A in glial cells. PLoS One 2011; 6:e21994; PMID:21755018; http://dx.doi.org/10.1371/journal.pone.0021994
47. Yu Q, Guo J, Zhou J. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10. J Neurochem 2004; 90:164-72; PMID:15198676; http://dx.doi.org/10.1111/j.1471-4159.2004.02477.x
48. Wang J, Gao QS, Wang Y, Lafyatis R, Stamm S, Andreadis A. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem 2004; 88:1078-90; PMID:15009664; http://dx.doi.org/10.1046/j.1471-4159.2003.02232.x
49. Hartmann AM, Rujescu D, Giannakouros T, Nikolakaki E, Goedert M, Mandelkow EM, Gao QS, Andreadis A, Stamm S. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors. Mol Cell Neurosci 2001; 18:80-90; PMID:11461155; http://dx.doi.org/10.1006/mcne.2001.1000
50. Hernandez F, Pérez M, Lucas JJ, Mata AM, Bhat R, Avila J. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease. J Biol Chem 2004; 279:3801-6; PMID:14602710; http://dx.doi.org/10.1074/jbc.M311512200
51. Smith PY, Delay C, Girard J, Papon MA, Planel E, Sergeant N, Buée L, Hébert SS. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 2011; 20:4016- 24; PMID:21807765; http://dx.doi.org/10.1093/hmg/ddr330
52. Walter AE, Turner DH, Kim J, Lyttle MH, Müller P, Mathews DH, Zuker M. Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci U S A 1994; 91:9218-22; PMID:7524072; http://dx.doi.org/10.1073/pnas.91.20.9218
53. Walter AE, Turner DH. Sequence dependence of stability for coaxial stacking of RNA helixes with Watson- Crick base paired interfaces. Biochemistry 1994; 33:12715-9; PMID:7522562
54. Kim J, Walter AE, Turner DH. Thermodynamics of coaxially stacked helixes with GA and CC mismatches. Biochemistry 1996; 35:13753-61; PMID:8901517; http://dx.doi.org/10.1021/bi960913z
55. Pasternak A, Kierzek E, Pasternak K, Fratczak A, Turner DH, Kierzek R. The thermodynamics of 3'-terminal pyrene and guanosine for the design of isoenergetic 2'-O-methyl-RNA-LNA chimeric oligonucleotide probes of RNA structure. Biochemistry 2008; 47:1249-58; PMID:18177022; http://dx.doi.org/10.1021/bi701758z
56. Beaucage SL, Caruthers MH. Deoxynucleoside phosphoramidites - a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Letters 1981; 22:1859-1862; http://dx.doi.org/10.1016/S0040-4039(01)90461-7
57. Xia T, SantaLucia J Jr, Burkard ME, Kierzek R, Schroeder SJ, Jiao X, Cox C, Turner DH. Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson- Crick base pairs. Biochemistry 1998; 37:14719-35; PMID:9778347
58. Kierzek E, Kierzek R. The synthesis of oligoribonucleotides containing N6-alkyladenosines and 2-methylthio- N6-alkyladenosines via post-synthetic modification of precursor oligomers. Nucleic Acids Res 2003; 31:4461-71; PMID:12888506; http://dx.doi.org/10.1093/nar/gkg632
59. Borer PN. Optical properties of nucleic acids, absorption and circular dichroism spectra. in CRC Handbook of Biochemistry and Molecular Biology: Nucleic Acids, 3rd edn., Vol. 1 (ed. Fasman GD) 589-595 (CRC Press, Cleveland, OH, 1975).
60. Richards EG. Use of tables in calculations of absorption, optical rotatory dispersion and circular dichroism of polyribonucleotides. in CRC Handbook of Biochemistry and Molecular Biology: Nucleic Acids, 3rd edn., Vol. 1 (ed. Fasman, G.D.) 596-603 (CRC Press, Cleveland, OH, 1975).
61. McDowell JA, Turner DH. Investigation of the structural basis for thermodynamic stabilities of tandem GU mismatches: solution structure of (rGAGGUCUC)2 by two-dimensional NMR and simulated annealing. Biochemistry 1996; 35:14077-89; PMID:8916893; http://dx.doi.org/10.1021/bi9615710
62. Fratczak A, Kierzek R, Kierzek E. LNA-modified primers drastically improve hybridization to target RNA and reverse transcription. Biochemistry 2009; 48:514- 6; PMID:19119855; http://dx.doi.org/10.1021/bi8021069
63. Burn TC, Connors TD, Klinger KW, Landes GM. Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene 1995; 161:183-7; PMID:7665076; http://dx.doi.org/10.1016/0378-1119(95)00223-S
64. Schneider B, Koppius A, Sedlmeier R. Use of an exontrapping vector for the evaluation of splice-site mutations. Mamm Genome 2007; 18:670-6; PMID:17687606; http://dx.doi.org/10.1007/s00335- 007-9047-z